{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:56:14Z","timestamp":1791888974368,"version":"4.3.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s40263-015-0230-6","type":"journal-article","created":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T06:51:48Z","timestamp":1424415108000},"page":"113-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":201,"title":["Antihypertensive Drugs, Prevention of Cognitive Decline and Dementia: A Systematic Review of Observational Studies, Randomized Controlled Trials and Meta-Analyses, with Discussion of Potential Mechanisms"],"prefix":"10.1007","volume":"29","author":[{"given":"Laure","family":"Rouch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Cestac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charl\u00e8ne","family":"Cool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Helmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Bouhanick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Chamontin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u04abois","family":"Dartigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Vellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Andrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,21]]},"reference":[{"issue":"9503","key":"230_CR1","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","volume":"366","author":"CP Ferri","year":"2005","unstructured":"Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366(9503):2112\u20137.","journal-title":"Lancet."},{"issue":"4","key":"230_CR2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/01.wnl.0000341271.90478.8e","volume":"72","author":"A Viswanathan","year":"2009","unstructured":"Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: how to move forward? Neurology. 2009;72(4):368\u201374.","journal-title":"Neurology."},{"issue":"8","key":"230_CR3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(05)70141-1","volume":"4","author":"C Qiu","year":"2005","unstructured":"Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4(8):487\u201399.","journal-title":"Lancet Neurol."},{"key":"230_CR4","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339\u2013b2535.","DOI":"10.1136\/bmj.b2535"},{"issue":"1","key":"230_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1\u201312.","journal-title":"Control Clin Trials."},{"issue":"5","key":"230_CR6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjopharm.2009.11.001","volume":"7","author":"K Shah","year":"2009","unstructured":"Shah K, Qureshi SU, Johnson M, Parikh N, Schulz PE, Kunik ME. Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review. Am J Geriatr Pharmacother. 2009;7(5):250\u201361.","journal-title":"Am J Geriatr Pharmacother."},{"issue":"13","key":"230_CR7","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archinternmed.2009.175","volume":"169","author":"KM Sink","year":"2009","unstructured":"Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, et al. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch Intern Med. 2009;169(13):1195\u2013202.","journal-title":"Arch Intern Med."},{"issue":"8","key":"230_CR8","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1097\/HJH.0b013e328301a280","volume":"26","author":"O Hanon","year":"2008","unstructured":"Hanon O, Berrou J-P, Negre-Pages L, Goch JH, N\u00e1dh\u00e1zi Z, Petrella R, et al. Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study. J Hypertens. 2008;26(8):1642\u201350.","journal-title":"J Hypertens."},{"key":"230_CR9","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","volume":"340","author":"N-C Li","year":"2010","unstructured":"Li N-C, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, et al. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ. 2010;340:b5465.","journal-title":"BMJ."},{"issue":"5","key":"230_CR10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jalz.2011.05.2414","volume":"8","author":"ML Johnson","year":"2012","unstructured":"Johnson ML, Parikh N, Kunik ME, Schulz PE, Patel JG, Chen H, et al. Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus. Alzheimers Dement J Alzheimers Assoc. 2012;8(5):437\u201344.","journal-title":"Alzheimers Dement J Alzheimers Assoc."},{"issue":"9","key":"230_CR11","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/jgs.12415","volume":"61","author":"ME Soto","year":"2013","unstructured":"Soto ME, van Kan GA, Nourhashemi F, Gillette-Guyonnet S, Cesari M, Cantet C, et al. Angiotensin-converting enzyme inhibitors and Alzheimer\u2019s disease progression in older adults: results from the R\u00e9seau sur la Maladie d\u2019Alzheimer Fran\u00e7ais Cohort. J Am Geriatr Soc. 2013;61(9):1482\u20138.","journal-title":"J Am Geriatr Soc."},{"issue":"7339","key":"230_CR12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/bmj.324.7339.699","volume":"324","author":"J Bosch","year":"2002","unstructured":"Bosch J, Yusuf S, Pogue J, Sleight P, Lonn E, Rangoonwala B, et al. Use of ramipril in preventing stroke: double blind randomised trial. BMJ. 2002;324(7339):699\u2013702.","journal-title":"BMJ."},{"issue":"10","key":"230_CR13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(08)70198-4","volume":"7","author":"H-C Diener","year":"2008","unstructured":"Diener H-C, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008;7(10):875\u201384.","journal-title":"Lancet Neurol."},{"issue":"9","key":"230_CR14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","volume":"163","author":"C Tzourio","year":"2003","unstructured":"Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163(9):1069\u201375.","journal-title":"Arch Intern Med."},{"issue":"1","key":"230_CR15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(10)70250-7","volume":"10","author":"C Anderson","year":"2011","unstructured":"Anderson C, Teo K, Gao P, Arima H, Dans A, Unger T, et al. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurol. 2011;10(1):43\u201353.","journal-title":"Lancet Neurol."},{"issue":"9","key":"230_CR16","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1212\/WNL.53.9.1948","volume":"53","author":"C Tzourio","year":"1999","unstructured":"Tzourio C, Dufouil C, Ducimeti\u00e8re P, Alp\u00e9rovitch A. Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of vascular aging. Neurology. 1999;53(9):1948\u201352.","journal-title":"Neurology."},{"issue":"18","key":"230_CR17","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1001\/archinte.162.18.2090","volume":"162","author":"MD Murray","year":"2002","unstructured":"Murray MD, Lane KA, Gao S, Evans RM, Unverzagt FW, Hall KS, et al. Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans. Arch Intern Med. 2002;162(18):2090\u20136.","journal-title":"Arch Intern Med."},{"issue":"1","key":"230_CR18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/gerona\/60.1.67","volume":"60","author":"I Hajjar","year":"2005","unstructured":"Hajjar I, Catoe H, Sixta S, Boland R, Johnson D, Hirth V, et al. Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population. J Gerontol A Biol Sci Med Sci. 2005;60(1):67\u201373.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"10","key":"230_CR19","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.0b013e3182a351d4","volume":"81","author":"RP Gelber","year":"2013","unstructured":"Gelber RP, Ross GW, Petrovitch H, Masaki KH, Launer LJ, White LR. Antihypertensive medication use and risk of cognitive impairment: the Honolulu-Asia Aging Study. Neurology. 2013;81(10):888\u201395.","journal-title":"Neurology."},{"issue":"2","key":"230_CR20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archneur.60.2.223","volume":"60","author":"C Qiu","year":"2003","unstructured":"Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch Neurol. 2003;60(2):223\u20138.","journal-title":"Arch Neurol."},{"issue":"5","key":"230_CR21","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","volume":"63","author":"AS Khachaturian","year":"2006","unstructured":"Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, et al. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol. 2006;63(5):686\u201392.","journal-title":"Arch Neurol."},{"issue":"5","key":"230_CR22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/01.STR.0000217653.01615.93","volume":"37","author":"R Peila","year":"2006","unstructured":"Peila R, White LR, Masaki K, Petrovitch H, Launer LJ. Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke J Cereb Circ. 2006;37(5):1165\u201370.","journal-title":"Stroke J Cereb Circ."},{"issue":"10","key":"230_CR23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1212\/WNL.0b013e3182a35228","volume":"81","author":"S Yasar","year":"2013","unstructured":"Yasar S, Xia J, Yao W, Furberg CD, Xue Q-L, Mercado CI, et al. Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. Neurology. 2013;81(10):896\u2013903.","journal-title":"Neurology."},{"issue":"20","key":"230_CR24","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1212\/01.wnl.0000345062.86148.3f","volume":"72","author":"MDM Haag","year":"2009","unstructured":"Haag MDM, Hofman A, Koudstaal PJ, Breteler MMB, Stricker BHC. Duration of antihypertensive drug use and risk of dementia: a prospective cohort study. Neurology. 2009;72(20):1727\u201334.","journal-title":"Neurology."},{"issue":"3","key":"230_CR25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0197-4580(00)00241-4","volume":"22","author":"BA In\u2019t Veld","year":"2001","unstructured":"In\u2019t Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging. 2001;22(3):407\u201312.","journal-title":"Neurobiol Aging."},{"issue":"10","key":"230_CR26","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archneur.58.10.1640","volume":"58","author":"MC Morris","year":"2001","unstructured":"Morris MC, Scherr PA, Hebert LE, Glynn RJ, Bennett DA, Evans DA. Association of incident Alzheimer disease and blood pressure measured from 13\u00a0years before to 2\u00a0years after diagnosis in a large community study. Arch Neurol. 2001;58(10):1640\u20136.","journal-title":"Arch Neurol."},{"issue":"5","key":"230_CR27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/aje\/kwf074","volume":"156","author":"J Lindsay","year":"2002","unstructured":"Lindsay J, Laurin D, Verreault R, H\u00e9bert R, Helliwell B, Hill GB, et al. Risk factors for Alzheimer\u2019s disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol. 2002;156(5):445\u201353.","journal-title":"Am J Epidemiol."},{"issue":"2","key":"230_CR28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2004.03.009","volume":"26","author":"S Yasar","year":"2005","unstructured":"Yasar S, Corrada M, Brookmeyer R, Kawas C. Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging. Neurobiol Aging. 2005;26(2):157\u201363.","journal-title":"Neurobiol Aging."},{"issue":"3","key":"230_CR29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):145\u201353.","journal-title":"N Engl J Med."},{"issue":"6824","key":"230_CR30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.304.6824.405","volume":"304","author":"No authors listed","year":"1992","unstructured":"No authors listed. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ. 1992;304(6824):405\u201312.","journal-title":"BMJ."},{"issue":"7034","key":"230_CR31","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/bmj.312.7034.801","volume":"312","author":"MJ Prince","year":"1996","unstructured":"Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54\u00a0months of the Medical Research Council\u2019s trial of hypertension in older adults. BMJ. 1996;312(7034):801\u20135.","journal-title":"BMJ."},{"issue":"5","key":"230_CR32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","volume":"21","author":"H Lithell","year":"2003","unstructured":"Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003;21(5):875\u201386.","journal-title":"J Hypertens."},{"issue":"18","key":"230_CR33","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","volume":"358","author":"NS Beckett","year":"2008","unstructured":"Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80\u00a0years of age or older. N Engl J Med. 2008;358(18):1887\u201398.","journal-title":"N Engl J Med."},{"issue":"8","key":"230_CR34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","volume":"7","author":"R Peters","year":"2008","unstructured":"Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol. 2008;7(8):683\u20139.","journal-title":"Lancet Neurol."},{"issue":"9080","key":"230_CR35","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","volume":"350","author":"JA Staessen","year":"1997","unstructured":"Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenh\u00e4ger WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350(9080):757\u201364.","journal-title":"Lancet."},{"issue":"9137","key":"230_CR36","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","volume":"352","author":"F Forette","year":"1998","unstructured":"Forette F, Seux ML, Staessen JA, Thijs L, Birkenh\u00e4ger WH, Babarskiene MR, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352(9137):1347\u201351.","journal-title":"Lancet."},{"issue":"18","key":"230_CR37","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","volume":"162","author":"F Forette","year":"2002","unstructured":"Forette F, Seux M-L, Staessen JA, Thijs L, Babarskiene M-R, Babeanu S, et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002;162(18):2046\u201352.","journal-title":"Arch Intern Med."},{"key":"230_CR38","doi-asserted-by":"crossref","unstructured":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265(24):3255\u201364.","DOI":"10.1001\/jama.1991.03460240051027"},{"issue":"19","key":"230_CR39","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1001\/archinte.1994.00420190047006","volume":"154","author":"WB Applegate","year":"1994","unstructured":"Applegate WB, Pressel S, Wittes J, Luhr J, Shekelle RB, Camel GH, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med. 1994;154(19):2154\u201360.","journal-title":"Arch Intern Med."},{"issue":"1","key":"230_CR40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/aje\/153.1.72","volume":"153","author":"M Bari Di","year":"2001","unstructured":"Di Bari M, Pahor M, Franse LV, Shorr RI, Wan JY, Ferrucci L, et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol. 2001;153(1):72\u20138.","journal-title":"Am J Epidemiol."},{"issue":"12","key":"230_CR41","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/j.1742-1241.2011.02810.x","volume":"65","author":"H Chang-Quan","year":"2011","unstructured":"Chang-Quan H, Hui W, Chao-Min W, Zheng-Rong W, Jun-Wen G, Yong-Hong L, et al. The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies. Int J Clin Pract. 2011;65(12):1295\u2013305.","journal-title":"Int J Clin Pract."},{"issue":"4","key":"230_CR42","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3233\/JAD-2011-111160","volume":"27","author":"J-W Guan","year":"2011","unstructured":"Guan J-W, Huang C-Q, Li Y-H, Wan C-M, You C, Wang Z-R, et al. No association between hypertension and risk for Alzheimer\u2019s disease: a meta-analysis of longitudinal studies. J Alzheimers Dis JAD. 2011;27(4):799\u2013807.","journal-title":"J Alzheimers Dis JAD."},{"key":"230_CR43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jns.2004.11.020","volume":"229\u2013230","author":"V Feigin","year":"2005","unstructured":"Feigin V, Ratnasabapathy Y, Anderson C. Does blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease? J Neurol Sci. 2005;229\u2013230:151\u20135.","journal-title":"J Neurol Sci."},{"issue":"10","key":"230_CR44","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/01.hjh.0000244934.81180.16","volume":"24","author":"J Birns","year":"2006","unstructured":"Birns J, Morris R, Donaldson N, Kalra L. The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials. J Hypertens. 2006;24(10):1907\u201314.","journal-title":"J Hypertens."},{"issue":"1","key":"230_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pcad.2006.03.001","volume":"49","author":"WH Birkenh\u00e4ger","year":"2006","unstructured":"Birkenh\u00e4ger WH, Staessen JA. Progress in cardiovascular diseases: cognitive function in essential hypertension. Prog Cardiovasc Dis. 2006;49(1):1\u201310.","journal-title":"Prog Cardiovasc Dis."},{"key":"230_CR46","first-page":"CD004034","volume":"4","author":"B McGuinness","year":"2009","unstructured":"McGuinness B, Todd S, Passmore P, Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev Online. 2009;4:CD004034.","journal-title":"Cochrane Database Syst Rev Online."},{"key":"230_CR47","first-page":"CD000147","volume":"3","author":"JM L\u00f3pez-Arrieta","year":"2002","unstructured":"L\u00f3pez-Arrieta JM, Birks J. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database Syst Rev. 2002;3:CD000147.","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"230_CR48","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/HJH.0b013e3283603f53","volume":"31","author":"N Levi Marpillat","year":"2013","unstructured":"Levi Marpillat N, Macquin-Mavier I, Tropeano A-I, Bachoud-Levi A-C, Maison P. Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens. 2013;31(6):1073\u201382.","journal-title":"J Hypertens."},{"issue":"4","key":"230_CR49","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.STR.28.4.785","volume":"28","author":"T Pohjasvaara","year":"1997","unstructured":"Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M. Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke. 1997;28(4):785\u201392.","journal-title":"Stroke."},{"issue":"1","key":"230_CR50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1212\/WNL.46.1.154","volume":"46","author":"E Kokmen","year":"1996","unstructured":"Kokmen E, Whisnant JP, O\u2019Fallon WM, Chu CP, Beard CM. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960\u20131984). Neurology. 1996;46(1):154\u20139.","journal-title":"Neurology"},{"issue":"8693","key":"230_CR51","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","volume":"335","author":"R Collins","year":"1990","unstructured":"Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335(8693):827\u201338 (Review).","journal-title":"Lancet"},{"key":"230_CR52","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/archinte.161.2.152","volume":"161","author":"WH Birkenh\u00e4ger","year":"2001","unstructured":"Birkenh\u00e4ger WH, Forette F, Seux ML, Wang JG, Staessen JA. Blood pressure, cognitive performance, and prevention of dementias in older patients with hypertension. Arch Intern Med. 2001;161:152\u20136.","journal-title":"Arch Intern Med"},{"issue":"1","key":"230_CR53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0197-4580(00)00096-8","volume":"21","author":"LJ Launer","year":"2000","unstructured":"Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, Havlik RJ. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000;21(1):49\u201355.","journal-title":"Neurobiol Aging"},{"key":"230_CR54","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1212\/01.WNL.0000159860.19413.C4","volume":"64","author":"OL Lopez","year":"2005","unstructured":"Lopez OL, Kuller LH, Becker JT, et al. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology. 2005;64:1539\u201347.","journal-title":"Neurology"},{"issue":"12","key":"230_CR55","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/jcbfm.2008.91","volume":"28","author":"AH Hainsworth","year":"2008","unstructured":"Hainsworth AH, Markus HS. Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. 2008;28(12):1877\u201391.","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab."},{"issue":"12","key":"230_CR56","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.STR.27.12.2262","volume":"27","author":"D Liao","year":"1996","unstructured":"Liao D, Cooper L, Cai J, Toole JF, Bryan NR, Hutchinson RG, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke J Cereb Circ. 1996;27(12):2262\u201370.","journal-title":"Stroke J Cereb Circ."},{"issue":"8","key":"230_CR57","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1161\/01.STR.0000024523.82311.77","volume":"33","author":"O-C Suter","year":"2002","unstructured":"Suter O-C, Sunthorn T, Kraftsik R, Straubel J, Darekar P, Khalili K, et al. Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke J Cereb Circ. 2002;33(8):1986\u201392.","journal-title":"Stroke J Cereb Circ."},{"issue":"3","key":"230_CR58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s004150050064","volume":"244","author":"F Pasquier","year":"1997","unstructured":"Pasquier F, Leys D. Why are stroke patients prone to develop dementia? J Neurol. 1997;244(3):135\u201342.","journal-title":"J Neurol."},{"issue":"6","key":"230_CR59","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0197-4580(86)90086-2","volume":"7","author":"JA Hardy","year":"1986","unstructured":"Hardy JA, Mann DM, Wester P, Winblad B. An integrative hypothesis concerning the pathogenesis and progression of Alzheimer\u2019s disease. Neurobiol Aging. 1986;7(6):489\u2013502.","journal-title":"Neurobiol Aging."},{"issue":"15","key":"230_CR60","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.1074\/jbc.M608856200","volume":"282","author":"X Zhang","year":"2007","unstructured":"Zhang X, Zhou K, Wang R, Cui J, Lipton SA, Liao F-F, et al. Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J Biol Chem. 2007;282(15):10873\u201380.","journal-title":"J Biol Chem."},{"issue":"3 Suppl","key":"230_CR61","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1161\/STROKEAHA.108.533638","volume":"40","author":"C Iadecola","year":"2009","unstructured":"Iadecola C, Park L, Capone C. Threats to the mind: aging, amyloid, and hypertension. Stroke J Cereb Circ. 2009;40(3 Suppl):S40\u20134.","journal-title":"Stroke J Cereb Circ."},{"key":"230_CR62","first-page":"817","volume":"17","author":"F Angeli","year":"2004","unstructured":"Angeli F, Verdecchia P, Reboldi GP, Gattobigio R, Bentivoglio M, Staessen JA, Porcellati C. Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103.793 subjects. Am J Hypertens. 2004;17:817\u201322.","journal-title":"Am J Hypertens"},{"issue":"7","key":"230_CR63","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s11064-010-0371-4","volume":"36","author":"MJ Berridge","year":"2011","unstructured":"Berridge MJ. Calcium signalling and Alzheimer\u2019s disease. Neurochem Res. 2011;36(7):1149\u201356.","journal-title":"Neurochem Res."},{"issue":"3","key":"230_CR64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1474-9726.2007.00295.x","volume":"6","author":"O Thibault","year":"2007","unstructured":"Thibault O, Gant JC, Landfield PW. Expansion of the calcium hypothesis of brain aging and Alzheimer\u2019s disease: minding the store. Aging Cell. 2007;6(3):307\u201317.","journal-title":"Aging Cell."},{"issue":"5264","key":"230_CR65","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1126\/science.272.5264.1017","volume":"272","author":"O Thibault","year":"1996","unstructured":"Thibault O, Landfield PW. Increase in single L-type calcium channels in hippocampal neurons during aging. Science. 1996;272(5264):1017\u201320.","journal-title":"Science."},{"issue":"5","key":"230_CR66","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1046\/j.1471-4159.2003.02227.x","volume":"88","author":"N Pierrot","year":"2004","unstructured":"Pierrot N, Ghisdal P, Caumont A-S, Octave J-N. Intraneuronal amyloid-beta1-42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death. J Neurochem. 2004;88(5):1140\u201350.","journal-title":"J Neurochem."},{"issue":"15","key":"230_CR67","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1021\/bi00181a016","volume":"33","author":"HW Querfurth","year":"1994","unstructured":"Querfurth HW, Selkoe DJ. Calcium ionophore increases amyloid beta peptide production by cultured cells. Biochemistry (Mosc). 1994;33(15):4550\u201361.","journal-title":"Biochemistry (Mosc)."},{"issue":"1","key":"230_CR68","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0896-6273(90)90447-N","volume":"4","author":"MP Mattson","year":"1990","unstructured":"Mattson MP. Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and Ca2+ influx in cultured hippocampal neurons. Neuron. 1990;4(1):105\u201317.","journal-title":"Neuron."},{"issue":"4","key":"230_CR69","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1568-1637(03)00029-1","volume":"2","author":"RA Nixon","year":"2003","unstructured":"Nixon RA. The calpains in aging and aging-related diseases. Ageing Res Rev. 2003;2(4):407\u201318.","journal-title":"Ageing Res Rev."},{"issue":"2","key":"230_CR70","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuron.2008.07.013","volume":"59","author":"KN Green","year":"2008","unstructured":"Green KN, LaFerla FM. Linking calcium to Abeta and Alzheimer\u2019s disease. Neuron. 2008;59(2):190\u20134.","journal-title":"Neuron."},{"issue":"2","key":"230_CR71","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuron.2008.06.008","volume":"59","author":"KV Kuchibhotla","year":"2008","unstructured":"Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu H-Y, Hyman BT, Bacskai BJ. Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron. 2008;59(2):214\u201325.","journal-title":"Neuron."},{"issue":"3","key":"230_CR72","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.pneurobio.2009.07.009","volume":"89","author":"J-T Yu","year":"2009","unstructured":"Yu J-T, Chang RC-C, Tan L. Calcium dysregulation in Alzheimer\u2019s disease: from mechanisms to therapeutic opportunities. Prog Neurobiol. 2009;89(3):240\u201355.","journal-title":"Prog Neurobiol."},{"issue":"4","key":"230_CR73","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1152\/physrev.1997.77.4.1081","volume":"77","author":"MP Mattson","year":"1997","unstructured":"Mattson MP. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev. 1997;77(4):1081\u2013132.","journal-title":"Physiol Rev."},{"issue":"2","key":"230_CR74","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1471-4159.2003.02020.x","volume":"87","author":"K Furukawa","year":"2003","unstructured":"Furukawa K, Wang Y, Yao PJ, Fu W, Mattson MP, Itoyama Y, et al. Alteration in calcium channel properties is responsible for the neurotoxic action of a familial frontotemporal dementia tau mutation. J Neurochem. 2003;87(2):427\u201336.","journal-title":"J Neurochem."},{"issue":"2","key":"230_CR75","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neurobiolaging.2006.10.006","volume":"29","author":"S Trompet","year":"2008","unstructured":"Trompet S, Westendorp RGJ, Kamper AM, de Craen AJM. Use of calcium antagonists and cognitive decline in old age. The Leiden 85-plus study. Neurobiol Aging. 2008;29(2):306\u20138.","journal-title":"Neurobiol Aging."},{"issue":"2","key":"230_CR76","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0006-8993(90)90294-L","volume":"507","author":"JM Barnes","year":"1990","unstructured":"Barnes JM, Barnes NM, Costall B, Horovitz ZP, Ironside JW, Naylor RJ, et al. Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition. Brain Res. 1990;507(2):341\u20133.","journal-title":"Brain Res."},{"issue":"45","key":"230_CR77","doi-asserted-by":"crossref","first-page":"37644","DOI":"10.1074\/jbc.M508460200","volume":"280","author":"ML Hemming","year":"2005","unstructured":"Hemming ML, Selkoe DJ. Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. J Biol Chem. 2005;280(45):37644\u201350.","journal-title":"J Biol Chem."},{"issue":"2","key":"230_CR78","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biocel.2004.07.009","volume":"37","author":"EE Tuppo","year":"2005","unstructured":"Tuppo EE, Arias HR. The role of inflammation in Alzheimer\u2019s disease. Int J Biochem Cell Biol. 2005;37(2):289\u2013305.","journal-title":"Int J Biochem Cell Biol."},{"issue":"1","key":"230_CR79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2002.00855.x","volume":"81","author":"JA Carson","year":"2002","unstructured":"Carson JA, Turner AJ. Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? J Neurochem. 2002;81(1):1\u20138.","journal-title":"J Neurochem."},{"issue":"11","key":"230_CR80","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1172\/JCI31547","volume":"117","author":"J Wang","year":"2007","unstructured":"Wang J, Ho L, Chen L, Zhao Z, Zhao W, Qian X, et al. Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest. 2007;117(11):3393\u2013402.","journal-title":"J Clin Invest."},{"issue":"3","key":"230_CR81","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbrc.2008.08.032","volume":"375","author":"M Mogi","year":"2008","unstructured":"Mogi M, Li J-M, Tsukuda K, Iwanami J, Min L-J, Sakata A, et al. Telmisartan prevented cognitive decline partly due to PPAR-gamma activation. Biochem Biophys Res Commun. 2008;375(3):446\u20139.","journal-title":"Biochem Biophys Res Commun."},{"issue":"1","key":"230_CR82","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/01.HYP.24.1.77","volume":"24","author":"RD McCabe","year":"1994","unstructured":"McCabe RD, Bakarich MA, Srivastava K, Young DB. Potassium inhibits free radical formation. Hypertension. 1994;24(1):77\u201382.","journal-title":"Hypertension."},{"issue":"5","key":"230_CR83","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3109\/10641969609081773","volume":"18","author":"T Ishimitsu","year":"1996","unstructured":"Ishimitsu T, Tobian L, Sugimoto K, Everson T. High potassium diets reduce vascular and plasma lipid peroxides in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens NYN 1993. 1996;18(5):659\u201373.","journal-title":"Clin Exp Hypertens NYN 1993."},{"issue":"5","key":"230_CR84","first-page":"477","volume":"19","author":"DB Young","year":"1999","unstructured":"Young DB, Ma G. Vascular protective effects of potassium. Semin Nephrol. 1999;19(5):477\u201386.","journal-title":"Semin Nephrol."},{"issue":"3","key":"230_CR85","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3181\/00379727-140-36560","volume":"140","author":"WT Chen","year":"1972","unstructured":"Chen WT, Brace RA, Scott JB, Anderson DK, Haddy FJ. The mechanism of the vasodilator action of potassium. Proc Soc Exp Biol Med Soc Exp Biol Med NYN. 1972;140(3):820\u20134.","journal-title":"Proc Soc Exp Biol Med Soc Exp Biol Med NYN."},{"issue":"8","key":"230_CR86","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","volume":"13","author":"S Norton","year":"2014","unstructured":"Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential form primary prevention of Alzheimer\u2019s disease: an analysis of population-based data. Lancet Neurol. 2014;13(8):788\u201394.","journal-title":"Lancet Neurol"},{"issue":"12","key":"230_CR87","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S1474-4422(07)70291-0","volume":"6","author":"S Seshadri","year":"2007","unstructured":"Seshadri S, Wolf PA. Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study. Lancet Neurol. 2007;6(12):1106\u201314.","journal-title":"Lancet Neurol"},{"key":"230_CR88","doi-asserted-by":"crossref","unstructured":"Schaller S, Mauskopf J, Kriza C, Wahlster P, Kolominsky-Rabas PL. The main cost drivers in dementia: a systematic review. Int J Geriatr Psychiatry. 2014. doi: 10.1002\/gps.4198 .","DOI":"10.1002\/gps.4198"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-015-0230-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-015-0230-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-015-0230-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T05:13:21Z","timestamp":1651295601000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-015-0230-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["230"],"URL":"https:\/\/doi.org\/10.1007\/s40263-015-0230-6","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}